Skip to content

Efficacy of Sublingual Midazolam in Association With Oral Morphine in Children Analgesia After Bone Fracture

Clinical Randomized Study of Sublingual Midazolam in Association With Morphine by Oral Route in Arm Fracture in Children at the Emergency Children Care

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00416039
Acronym
MIDAZODOL
Enrollment
60
Registered
2006-12-27
Start date
2007-01-31
Completion date
2009-02-28
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fractures

Keywords

midazolam, sublingual, oral morphine, children, bone fracture, bone fracture with a deformed member

Brief summary

It is a randomized simple-blind monocentric study; the group A will receive oral morphine with placebo and the group B will receive oral morphine with sublingual midazolam. The aim of this study is to show a more important pain decrease in the group taking midazolam versus placebo.

Detailed description

Fracture is often responsible of pain in the paediatric emergency department (ED). This pain is very severe and needs effective drugs. During a study made at the ED of Necker Enfants Malades Hospital, it has been shown that the oral morphine had a limited action on this kind of pain. Therefore it is interesting to increase the analgesia by making a drug association, for example with the midazolam witch is a benzodiazepine with a sedative and anxiolytic action, and which has got the MMA for the intravenous and the intra rectal forms for children older than 6 months. The intravenous form has some disadvantages like an extra work and an increase of risk of side effects. That is why the sublingual form seems to be interesting in this context. Even if some studies have shown the benefit of midazolam as a preanesthetic medication given to children scheduled for a surgical procedure, none has shown the interest of sublingual midazolam associated with oral morphine to relieve the pain due to a displaced fracture. The aim of this study is to show a more important pain decrease in the group taking midazolam versus placebo. It is a randomized simple-blind monocentric study; the group A will receive oral morphine with placebo and the group B will receive oral morphine with sublingual midazolam . The pain will be quantified thanks to the visual analogical scale (VAS)before and 30 minutes after the drugs administration, and we will try to show a difference of 15 points(on 100) of the VAS at 30 minutes between the two groups. 60 patients aged from 5 to 16 years old and having a displaced fracture will be enrolled in this study which will last 1 year. Patients having a contra-indication for morphine and midazolam won't be enrolled as patients with femoral fracture which needs a local anaesthesia.

Interventions

DRUGMidazolam

0.2 mg/kg of sublingual midazolam and 0.5 mg/kg of morphine

DRUGPlacebo

placebo at 0.2 mg/kg and morphine 0.5 mg/kg

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
5 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* children between 5 and 16 years old * children with a disjoined bone fracture * children needed oral morphine analgesia * written informed consent from one or the two parents or legal pad

Exclusion criteria

* ASA score \> 2 * concomitant administration of oral analgesia (level II WHO classification) less than 6 hours * concomitant administration of benzodiazepine less than 24 hours

Design outcomes

Primary

MeasureTime frame
Difference in the measurement of pain analogical scale values at 30 minutes between the two groupsafter administration until 120 minutes

Secondary

MeasureTime frame
Pain Analogical scale Values at 15, 30 minutes, 1 hour, 1h30 and 2 hours.after administration until 120 minutes
Respiratory rate, Oxymetryafter administration until 120 minutes
Conscience (lethargy or irritability)after administration until 120 minutes
Pain Analogical scale Values after the treatment of the fractureafter administration until 120 minutes
skin hyperesthesia, rashafter administration until 120 minutes
children cooperationafter surgical procedure
nausea,after administration until 120 minutes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026